SRTS Quote, Financials, Valuation and Earnings

AVITA Medical, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -77.29%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat AVITA Medical, Inc.'s return on equity of -1112.54%.

Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 82.88%. On the other hand AVITA Medical, Inc. has an analysts' consensus of $7.92 which suggests that it could grow by 124.65%. Given that AVITA Medical, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe AVITA Medical, Inc. is more attractive than Sensus Healthcare, Inc..

Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison AVITA Medical, Inc. has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.807%.

Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AVITA Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. AVITA Medical, Inc. pays out -- of its earnings as a dividend.

Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are smaller than AVITA Medical, Inc. quarterly revenues of $17.1M. Sensus Healthcare, Inc.'s net income of -$943K is higher than AVITA Medical, Inc.'s net income of -$13.2M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while AVITA Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.84x versus 1.30x for AVITA Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -862.39%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat VolitionRX Ltd.'s return on equity of --.

Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 82.88%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that VolitionRX Ltd. has higher upside potential than Sensus Healthcare, Inc., analysts believe VolitionRX Ltd. is more attractive than Sensus Healthcare, Inc..

Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Sensus Healthcare, Inc.'s net income of -$943K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.84x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -1037.17%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 82.88%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Catheter Precision, Inc. is more attractive than Sensus Healthcare, Inc..

Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Sensus Healthcare, Inc.'s net income of -$943K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.84x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of 3.93%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 82.88%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Sensus Healthcare, Inc..

Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Sensus Healthcare, Inc.'s net income of -$943K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.84x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.